CINECA IRIS Institutional Research Information System

CAVALIERE, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 844
AS - Asia 634
EU - Europa 378
Continente sconosciuto - Info sul continente non disponibili 131
SA - Sud America 50
AF - Africa 11
OC - Oceania 2
Totale 2.050
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 760
IT - Italia 283
BD - Bangladesh 172
CN - Cina 145
SG - Singapore 129
HK - Hong Kong 72
VN - Vietnam 47
CA - Canada 44
BR - Brasile 21
FR - Francia 18
NL - Olanda 15
DE - Germania 13
GB - Regno Unito 12
IN - India 10
AR - Argentina 8
MX - Messico 8
IQ - Iraq 7
CR - Costa Rica 6
JM - Giamaica 6
JP - Giappone 6
TR - Turchia 6
FI - Finlandia 5
MY - Malesia 5
PL - Polonia 5
SA - Arabia Saudita 5
CL - Cile 4
CO - Colombia 4
ES - Italia 4
HU - Ungheria 4
IL - Israele 4
KR - Corea 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
HN - Honduras 3
ID - Indonesia 3
NI - Nicaragua 3
PE - Perù 3
PK - Pakistan 3
RU - Federazione Russa 3
SV - El Salvador 3
UA - Ucraina 3
VE - Venezuela 3
ZA - Sudafrica 3
EG - Egitto 2
GR - Grecia 2
JO - Giordania 2
KE - Kenya 2
PH - Filippine 2
PY - Paraguay 2
UY - Uruguay 2
AL - Albania 1
AT - Austria 1
AU - Australia 1
BE - Belgio 1
BO - Bolivia 1
BS - Bahamas 1
DZ - Algeria 1
EC - Ecuador 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
GY - Guiana 1
HT - Haiti 1
IE - Irlanda 1
IR - Iran 1
KW - Kuwait 1
LC - Santa Lucia 1
LT - Lituania 1
MA - Marocco 1
MD - Moldavia 1
ML - Mali 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SE - Svezia 1
SI - Slovenia 1
TC - Turks e Caicos 1
TH - Thailandia 1
TW - Taiwan 1
UZ - Uzbekistan 1
VC - Saint Vincent e Grenadine 1
YE - Yemen 1
Totale 1.919
Salva come PNG Salva come JPEG
Città #
Ashburn 133
Beijing 75
Hong Kong 72
New York 59
Rome 51
San Jose 50
Santa Clara 45
Singapore 34
Milan 31
Los Angeles 30
Dallas 23
Princeton 22
Hanoi 20
Council Bluffs 16
Abbeville 14
Hillsboro 13
Naples 13
Bologna 11
Ho Chi Minh City 10
Buffalo 9
Chicago 9
Toronto 9
Florence 8
Phoenix 8
Brooklyn 7
Orem 7
Houston 6
Montreal 6
San Francisco 6
Warsaw 6
Frankfurt am Main 5
Istanbul 5
Las Vegas 5
Atlanta 4
Baghdad 4
Bari 4
Brescia 4
Bridgeport 4
Da Nang 4
Genoa 4
Helsinki 4
Kingston 4
Kuala Lumpur 4
Lima 4
Mexico City 4
Modena 4
Palermo 4
Pasadena 4
San Diego 4
Turin 4
Washington 4
Boardman 3
Budapest 3
Catania 3
Dubai 3
Jeddah 3
London 3
Managua 3
Marseille 3
Monza 3
Padua 3
Philadelphia 3
San José 3
San Salvador 3
Seattle 3
Seoul 3
Verona 3
Aci Catena 2
Amsterdam 2
Avellino 2
Baltimore 2
Cairo 2
Calgary 2
Civitanova Marche 2
Cleveland 2
Concordia 2
Cosenza 2
Covington 2
Dammam 2
Dhaka 2
Edmond 2
Figino 2
Flero 2
Florissant 2
Haiphong 2
Hanover 2
Heredia 2
Hialeah 2
Kansas City 2
Lancenigo-Villorba 2
Leiden 2
Milwaukee 2
Minneapolis 2
Mumbai 2
Nairobi 2
Natal 2
New Delhi 2
Newark 2
Newport News 2
Ninh Bình 2
Totale 1.004
Salva come PNG Salva come JPEG
Nome #
Systematic Review of Parotid Gland Sarcomas: Multi-Variate Analysis of Clinicopathologic Findings, Therapeutic Approaches and Oncological Outcomes That Affect Survival Rate 84
TIVA and TCI in Modern Anesthesia 83
Atrial fibrillation in the perioperative period 60
Effects of the Silica Dust on the Nasal Mucosa of Ceramic Workers 49
Real‐World Effectiveness of Mepolizumab in Patients With Chronic Rhinosinusitis With Nasal Polyps: Findings From the European CRS Outcome Registry (CHRINOSOR) 47
Remission in chronic rhinosinusitis with nasal polyps treated with biologics: a real-life experience 46
Indication for biologics in a real-world cohort of dupilumab treated chronic rhinosinusitis with nasal polyps patients according to international recommendations: evidence from the European CRS Outcome Registry (CHRINOSOR) 43
Allergic rhinitis in professional singers: a monoinstitutional series 37
Normative data for interpreting the SNOT-22 37
Two-year turning point with dupilumab in CRSwNP. Control, remission, and tapering dosage 36
The skin prick test 33
Benralizumab reduces eosinophils and inflammatory markers in patients with severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: a pilot real-life study 32
The Oral Microbiota: Implications in Mucosal Health and Systemic Disease—Crosstalk with Gut and Brain 32
DUPILUMAB-INDUCED BLOOD EOSINOPHILIA IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS: TEMPORAL TRENDS AND CORRELATION WITH ADVERSE EVENTS 31
Survey on use of local and systemic corticosteroids in the management of chronic rhinosinusitis with nasal polyps: identification of unmet clinical needs 30
A survey on features of allergic rhinitis in children 30
Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real-life study (DUPIREAL) 29
Transoral laser microsurgery for Tis, T1, and T2 glottic carcinoma: 5-year follow-up 27
Diagnostic applications of artificial intelligence in chronic rhinosinusitis: a systematic review 27
Diagnostic performance of nasal cytology 27
Pre-biologic FeNO might predict anti-IL-5/IL-5Rα response to treatment in severe asthmatics 26
Organi di senso. Manuale per l'approccio integrato alle patologie testa-collo 26
Mepolizumab effectiveness for patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps in Italy (MEPOREAL): a real-life, multicentre, phase 4 trial 23
Long-term perspectives on chronic rhinosinusitis with nasal polyps: evaluating recurrence rates after functional endoscopic sinus surgery in the biologics era—a 5-year follow-up study 22
Clinical and immunological effects of a treatment with desentizating low-dose multicomponents in IgE mediated and non IgE mediated food allergies: observational retrospective pilot study 21
Characterization of Chronic Rhinosinusitis Patients Based on Markers of Type 2 Inflammation: Findings From the European CRS Outcome Registry (CHRINOSOR) 21
The emerging role of MicroRNAs in nasal inflammatory diseases and tumors: from bench to bedside 20
Practical recommendations for managing severe chronic rhinosinusitis with nasal polyps in the era of biologics 20
Influence of Multiple Prior Endoscopic Sinus Surgeries on Dupilumab Efficacy Including Smell Function in the DUPIREAL Population 19
Evaluation of the Antihistamine and Anti-Inflammatory Effects of a Nutraceutical Blend Based on Quercetin, Perilla frutescens, Boswellia serrata, Blackcurrant, Parthenium, Helichrysum, Lactobacillus acidophilus and Bifidobacterium animalis Through In Vitro and In Vivo Approaches—Preliminary Data 19
Chronic rhinosinusitis with nasal polyps: a survey on routine management and evaluation of disease control in practice 19
Dupilumab’s impact on blood parameters in nasal polyposis: 18-month follow-up in real life 18
The safety of sublingual immunotherapy, can the rare systemic reactions be prevented? 18
Pollens causing allergy and their monitoring by aerobiology and phenology 18
Strategies for Tapering the Dosage of Biologics Targeting Type 2 Inflammation: A Systematic Review 17
Therapeutic strategies to prevent the recurrence of nasal polyps after surgical treatment: an update and in vitro study on growth inhibition of fibroblasts 17
International consensus statement on allergy and rhinology: Allergic rhinitis - 2023 17
Can patient-reported outcomes and inflammatory markers define endotype 2 in chronic rhinosinusitis without nasal polyps? 17
Management of patients with chronic rhinosinusitis and nasal polyposis in Italy: expert opinion on the diagnostic-therapeutic approach (La gestione del paziente con rinosinusite cronica e poliposi nasale in Italia: expert opinion sul percorso diagnostico-terapeutico) 16
Nasal cytology 16
Long-term omalizumab efficacy in allergic rhinitis 16
Chronic rhinosinusitis outcome registry (CHRINOSOR): establishment of an international outcome registry driven by mHealth technology 16
Mepolizumab effectiveness and allergic status in real life 16
Nasal cytology identifies allergic rhinitis phenotypes for managing allergen immunotherapy in clinical practice 15
Real-life evidence of Mepolizumab treatment in chronic rhinosinusitis with nasal polyps: a multicentric study 15
Systematic review of parotid gland sarcomas: multi-variate analysis of clinicopathologic findings, therapeutic approaches and oncological outcomes that affect survival rate 15
Effects of omalizumab therapy on allergic rhinitis: a pilot study 15
Factors reducing omalizumab response in severe asthma 15
The impact of antibiotics and steroids on the nasal microbiome in patients with chronic rhinosinusitis: a systematic review according to PICO criteria 15
Perceptual, aerodynamic and acoustic outcomes of surgical technique for sulcus vocalis patients: a systematic review and meta analysis 15
Adjuvant therapy with tablets containing sodium jaluronate, carbomer and xantam gum for gerd pharyngitis 14
Patient-specific factors to differentiate between branchial cleft cysts and CUP syndrome: a 10 year unicenter study 14
Postoperative Pain Management 14
Should omalizumab be used in severe asthma/COPD overlap? 14
Systematic review of parotid gland sarcomas: multi-variate analysis of clinicopathologic findings, therapeutic approaches and oncological outcomes that affect survival rate 14
Use of balloon catheter dilation vs. traditional endoscopic sinus surgery in management of light and severe chronic rhinosinusitis of the frontal sinus: a multicenter prospective randomized study 14
Laboratory tests for allergy diagnosis 14
Allergic conjunctivitis: current concepts on pathogenesis and management 14
Asthma associated to rhinitis 14
High-definition 3D exoscope in pediatric otorhinolaryngology: a systematic literature review 13
Sensitization to Gibberellin-regulated protein (Peamaclein) among Italian cypress pollen-sensitized patients 13
The role of allergoids in allergen immunotherapy: from injective to sublingual route 13
Therapeutic applications of capsaicin in upper airways 13
Bilateral and ipsilateral central neck dissection in total thyroidectomy: a long term comparison of complications 13
How to predict the outcome of septorhinoplasty? A normative study of ROE and FROI-17 scores 13
Comparison between clinical and cytological findings in chronic rhinosinusitis with nasal polyps treated with dupilumab 13
Real-world effectiveness of dupilumab in a european cohort of chronic rhinosinusitis with nasal polyps (CHRINOSOR) 13
Does a closed reduction improve aesthetical and functional outcome after nasal fracture? 13
Safety and adverse reactions in subcutaneous allergen immunotherapy: a review 12
Indication for biologic treatment in a real-world cohort of chronic rhinosinusitis patients according to international recommendations: Evidence from the European CRS outcome registry (CHRINOSOR) 12
The prevalence of complications in chronic allergic rhinitis 12
EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: definitions and management 12
The Sinonasal Microbiome in ENP 12
Targeting neuroinflammation to alleviate chronic olfactory dysfunction in Long COVID: a role for investigating disease-modifying therapy (DMT)? 12
Cypress pollen: an unexpected major sensitizing agent in different regions of Italy 11
Role of imaging in allergic rhinology 11
Long-term subjective and objective assessment of smell and taste in COVID-19 11
Changes of NGF pathway in allergic rhinoconjunctivitis: a conjunctival allergen challenge study 11
Real-world effectiveness of omalizumab in patients with chronic rhinosinusitis with nasal polyps (CRSwNP): findings from CHRINOSOR 11
Kurzfristige lebensqualitätsbewertung nach nasennebenhöhlenoperation bei chronischer rhinosinusitis [Short-term quality of life assessment after sinus surgery for chronic rhinosinusitis] 11
Perioperative management of patients affected by ischemic cardiomyopathy 11
Allergic rhinitis 11
Higher blood eosinophil levels after omalizumab treatment are associated with poorer asthma outcomes 11
Diagnosis of obstructive sleep apnea in patients with allergic and non-allergic rhinitis 11
Allergen immunotherapy management during vaccinations: an international survey 10
Correlation between olfactory function, age, sex, and cognitive reserve index in the Italian population 10
Human nasal immune system: a special site for immune response establishment 10
Characteristics of candidates for allergen immunotherapy 10
Endotypes of chronic rhinosinusitis with nasal polyps: pathology and possible therapeutic implications 9
Biologics for chronic rhinosinusitis with nasal polyps 9
Recovery of smell sense loss by mepolizumab in a patient allergic to dermatophagoides and affected by chronic rhinosinusitis with nasal polyps 9
Requirements for acquiring a high-quality house dust mite extract for allergen immunotherapy 9
Role of invariant natural killer t cells in patients with tonsillar hypertrophy: the tonsil as an immunological organ 9
The role of allergen-specific immunotherapy in ENT diseases: a systematic review 8
Total versus completion thyroidectomy: a multidimensional evaluation of long-term vocal alterations 8
Study on the use of focus harmonic scalpel in thyroidectomies. Is it useful also in preserving voice function? 8
Effects of paraprobiotic MIMLh5 in the treatment of chronic rhinopharyngitis 8
Impact of the COVID-19 pandemic on paediatric otolaryngology: a nationwide study 8
Nasal expression of the vascular endothelial growth factor and its receptors is reduced by mepolizumab in chronic rhinosinusitis with nasal polyposis 8
Eosinophilic lingual tonsillitis induced by sublingual immunotherapy: a case series 8
Totale 1.929
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.064
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.064
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20235 0 0 0 0 0 1 1 0 0 1 2 0
2023/20247 3 1 0 0 0 1 0 2 0 0 0 0
2024/202515 0 1 0 0 0 2 1 3 3 1 3 1
2025/20261.441 1 1 4 0 217 108 109 182 173 188 207 251
2026/2027582 164 187 99 132 0 0 0 0 0 0 0 0
Totale 2.050